The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer
Official Title: A Phase II, Open-Label, Randomized, Parallel-Group Multicenter Trial Comparing Two Schedules of GW572016 as First-Line Monotherapy in Patients With Advanced or Metastatic Breast Cancer
Study ID: NCT00089999
Brief Summary: This phase II study will evaluate and compare the efficacy and tolerability of two dose schedules (1500 mg QD and 500 mg BID) of oral Lapatinib as treatment for patients with advanced or metastatic breast cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
GSK Investigational Site, Hollywood, Florida, United States
GSK Investigational Site, Santiago, Regi贸n Metro De Santiago, Chile
GSK Investigational Site, Santiago, Regi贸n Metro De Santiago, Chile
GSK Investigational Site, Santiago, Regi贸n Metro De Santiago, Chile
GSK Investigational Site, Pokfulam, , Hong Kong
GSK Investigational Site, Delhi, , India
GSK Investigational Site, Hyderabad, Andhra Pradesh, , India
GSK Investigational Site, Pune, , India
GSK Investigational Site, Bandar Tun Razak, Cheras, , Malaysia
GSK Investigational Site, Kubang Kerian, , Malaysia
GSK Investigational Site, Tanjong Bungah, , Malaysia
GSK Investigational Site, Tanjong Bungah, , Malaysia
GSK Investigational Site, Ixtaltepec / Espinal, Oaxaca, Mexico
GSK Investigational Site, Merida, Yucat谩n, Mexico
GSK Investigational Site, Mexico, , Mexico
GSK Investigational Site, Karachi, , Pakistan
GSK Investigational Site, Karachi, , Pakistan
GSK Investigational Site, Karachi, , Pakistan
GSK Investigational Site, Lahore, , Pakistan
GSK Investigational Site, Rawalpindi, , Pakistan
GSK Investigational Site, Callao, , Peru
GSK Investigational Site, Lima, , Peru
GSK Investigational Site, Lima, , Peru
GSK Investigational Site, Lima, , Peru
GSK Investigational Site, Bydogoszcz, , Poland
GSK Investigational Site, Krakow, , Poland
GSK Investigational Site, Olsztyn, , Poland
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Taipei, , Taiwan
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR